Effects of interferon therapy in “non responder” patients with chronic hepatitis C

This publication has 31 references indexed in Scilit:

• Interferon Alfa-2b Alone or in Combination with Ribavirin as Initial Treatment for Chronic Hepatitis C
  New England Journal of Medicine, 1998
• Randomised trial of interferon α2b plus ribavirin for 48 weeks or for 24 weeks versus interferon α2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus
  Published by Elsevier ,1998
• Meta–Analysis of Interferon Randomized Trials in the Treatment of Viral Hepatitis C: Effects of Dose and Duration
  Hepatology, 1996
• Actions of cytokines on the immune response and viral interactions: An overview
  Hepatology, 1996
• A Comparison of Three Interferon Alfa-2b Regimens for the Long-Term Treatment of Chronic Non-A, Non-B Hepatitis
  New England Journal of Medicine, 1995
• High sustained response rate and clearance of viremia in chronic hepatitis C after treatment with interferon-α2b for 60 weeks
  Hepatology, 1994
• Discrepancy between biochemical and virological responses to interferon-$alpha; in chronic hepatitis C
  The Lancet, 1993
• Quantitative analysis of hepatitis C virus RNA in serum during interferon alfa therapy
  Gastroenterology, 1993
• Decrease in Serum Hepatitis C Viral RNA during Alpha-Interferon Therapy for Chronic Hepatitis C
  Annals of Internal Medicine, 1991
• Treatment of Chronic Non-A, Non-B Hepatitis with Recombinant Human Alpha Interferon
  New England Journal of Medicine, 1986